Wednesday, January 14, 2009
Gilead to Start Advanced Trial of First Four-in-One AIDS Drug
Gilead to Start Advanced Trial of First Four-in-One AIDS Drug: "Gilead Sciences Inc. expects to begin the first trial to test the effectiveness of its experimental four-in-one AIDS-drug pill early in the second half of this year, President John Milligan said in an interview.
Gilead, based in Foster City, California, is in discussions with the Food and Drug Administration about the size and scope of the trial, Milligan said today in an interview during the JP Morgan Healthcare Conference in San Francisco. The trial also will evaluate the safety of the Quad pill."
Gilead, based in Foster City, California, is in discussions with the Food and Drug Administration about the size and scope of the trial, Milligan said today in an interview during the JP Morgan Healthcare Conference in San Francisco. The trial also will evaluate the safety of the Quad pill."
